These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17606560)

  • 1. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.
    Watterberg KL; Shaffer ML; Mishefske MJ; Leach CL; Mammel MC; Couser RJ; Abbasi S; Cole CH; Aucott SW; Thilo EH; Rozycki HJ; Lacy CB
    Pediatrics; 2007 Jul; 120(1):40-8. PubMed ID: 17606560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.
    Watterberg KL; Gerdes JS; Cole CH; Aucott SW; Thilo EH; Mammel MC; Couser RJ; Garland JS; Rozycki HJ; Leach CL; Backstrom C; Shaffer ML
    Pediatrics; 2004 Dec; 114(6):1649-57. PubMed ID: 15574629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Wilson-Costello D; Walsh MC; Langer JC; Guillet R; Laptook AR; Stoll BJ; Shankaran S; Finer NN; Van Meurs KP; Engle WA; Das A;
    Pediatrics; 2009 Mar; 123(3):e430-7. PubMed ID: 19204058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.
    Stark AR; Carlo WA; Vohr BR; Papile LA; Saha S; Bauer CR; Oh W; Shankaran S; Tyson JE; Wright LL; Poole WK; Das A; Stoll BJ; Fanaroff AA; Korones SB; Ehrenkranz RA; Stevenson DK; Peralta-Carcelen M; Wilson-Costello DE; Bada HS; Heyne RJ; Johnson YR; Lee KG; Steichen JJ;
    J Pediatr; 2014 Jan; 164(1):34-39.e2. PubMed ID: 23992673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental outcomes of extremely low birthweight infants randomised to different PCO
    Thome UH; Genzel-Boroviczeny O; Bohnhorst B; Schmid M; Fuchs H; Rohde O; Avenarius S; Topf HG; Zimmermann A; Faas D; Timme K; Kleinlein B; Buxmann H; Schenk W; Segerer H; Teig N; Bläser A; Hentschel R; Heckmann M; Schlösser R; Peters J; Rossi R; Rascher W; Böttger R; Seidenberg J; Hansen G; Zernickel M; Bode H; Dreyhaupt J; Muche R; Hummler HD;
    Arch Dis Child Fetal Neonatal Ed; 2017 Sep; 102(5):F376-F382. PubMed ID: 28087725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
    Ohls RK; Ehrenkranz RA; Das A; Dusick AM; Yolton K; Romano E; Delaney-Black V; Papile LA; Simon NP; Steichen JJ; Lee KG;
    Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone.
    Lee BH; Stoll BJ; McDonald SA; Higgins RD;
    Pediatrics; 2008 Feb; 121(2):289-96. PubMed ID: 18245420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.
    Bierer R; Peceny MC; Hartenberger CH; Ohls RK
    Pediatrics; 2006 Sep; 118(3):e635-40. PubMed ID: 16908620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year neurodevelopmental outcomes of extremely preterm infants treated with early hydrocortisone: treatment effect according to gestational age at birth.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F30-F35. PubMed ID: 29321180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.
    Kobaly K; Schluchter M; Minich N; Friedman H; Taylor HG; Wilson-Costello D; Hack M
    Pediatrics; 2008 Jan; 121(1):73-81. PubMed ID: 18166559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide.
    Mestan KK; Marks JD; Hecox K; Huo D; Schreiber MD
    N Engl J Med; 2005 Jul; 353(1):23-32. PubMed ID: 16000353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
    Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
    Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis.
    Hintz SR; Kendrick DE; Stoll BJ; Vohr BR; Fanaroff AA; Donovan EF; Poole WK; Blakely ML; Wright L; Higgins R;
    Pediatrics; 2005 Mar; 115(3):696-703. PubMed ID: 15741374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants.
    Watterberg KL; Gerdes JS; Gifford KL; Lin HM
    Pediatrics; 1999 Dec; 104(6):1258-63. PubMed ID: 10585975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomes.
    Walden RV; Taylor SC; Hansen NI; Poole WK; Stoll BJ; Abuelo D; Vohr BR;
    Pediatrics; 2007 Dec; 120(6):e1512-9. PubMed ID: 17984212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998.
    Vohr BR; Wright LL; Poole WK; McDonald SA
    Pediatrics; 2005 Sep; 116(3):635-43. PubMed ID: 16143580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.